Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 468176016 | Sodium hyaluronate+sodium chondroitin sulphate 30mg/40mg/1mL intra-ocular injection prefilled syringe | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 468177013 | Sodium hyaluronate+sodium chondroitin sulfate 30mg/40mg/1mL intra-ocular injection prefilled syringe | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1192302016 | Sodium hyaluronate+sodium chondroitin sulfate 30mg/40mg/1mL intra-ocular injection prefilled syringe (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 4732991000005115 | natriumhyaluronat 30 mg/1 ml + natriumchondroitinsulfat 40 mg/1 ml intraokulær injektionsvæske, i fyldt injektionssprøjte | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Danish module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| natriumhyaluronat 30 mg/1 ml + natriumchondroitinsulfat 40 mg/1 ml intraokulær injektionsvæske, i fyldt injektionssprøjte | Is a | hyaluronatnatrium | false | Inferred relationship | Some | ||
| natriumhyaluronat 30 mg/1 ml + natriumchondroitinsulfat 40 mg/1 ml intraokulær injektionsvæske, i fyldt injektionssprøjte | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Sodium hyaluronate | false | Inferred relationship | Some | ||
| natriumhyaluronat 30 mg/1 ml + natriumchondroitinsulfat 40 mg/1 ml intraokulær injektionsvæske, i fyldt injektionssprøjte | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Sodium chondroitin sulfate (substance) | false | Inferred relationship | Some | ||
| natriumhyaluronat 30 mg/1 ml + natriumchondroitinsulfat 40 mg/1 ml intraokulær injektionsvæske, i fyldt injektionssprøjte | Is a | natriumchondroitinsulfat | false | Inferred relationship | Some | ||
| natriumhyaluronat 30 mg/1 ml + natriumchondroitinsulfat 40 mg/1 ml intraokulær injektionsvæske, i fyldt injektionssprøjte | Has manufactured dose form | injektionsvæske | false | Inferred relationship | Some | ||
| natriumhyaluronat 30 mg/1 ml + natriumchondroitinsulfat 40 mg/1 ml intraokulær injektionsvæske, i fyldt injektionssprøjte | Is a | oftalmisk hyaluronatnatrium | false | Inferred relationship | Some | ||
| natriumhyaluronat 30 mg/1 ml + natriumchondroitinsulfat 40 mg/1 ml intraokulær injektionsvæske, i fyldt injektionssprøjte | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR